APH and ALL Cannabis Biggest Seller Anonymous

Biggest Seller Anonymous

House Positions for C:APH from 20180611 to 20180611

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
1 Anonymous	1,116,174	13,177,678	11.806	1,321,271	15,631,055	11.83	-205,097	2,453,377
65 Goldman	1,721	20,392	11.849	120,100	1,414,531	11.778	-118,379	1,394,139
13 Instinet	87,250	1,033,514	11.845	136,600	1,610,284	11.788	-49,350	576,770
79 CIBC	713,821	8,431,164	11.811	746,317	8,819,421	11.817	-32,496	388,257
15 UBS	260	3,146	12.10	31,700	373,936	11.796	-31,440	370,790
39 Merrill Lynch	178,851	2,117,292	11.838	202,455	2,392,258	11.816	-23,604	274,966
89 Raymond James	2,200	25,866	11.757	20,936	247,336	11.814	-18,736	221,470
28 BBS	8,973	105,727	11.783	18,320	216,914	11.84	-9,347	111,187
9 BMO Nesbitt	253,446	2,995,819	11.82	258,511	3,041,998	11.767	-5,065	46,179
33 Canaccord	141,020	1,670,015	11.842	145,400	1,718,440	11.819	-4,380	48,425
143 Pershing	8,154	96,410	11.824	11,399	134,134	11.767	-3,245	37,724
36 Latimer	300	3,552	11.84	1,557	18,577	11.931	-1,257	15,025
56 Edward Jones	0			750	8,885	11.847	-750	8,885
76 Industrial Alliance	0			500	5,913	11.826	-500	5,913
83 Mackie	5,000	59,717	11.943	5,000	60,600	12.12	0	883
48 Laurentian	500	6,000	12.00	500	5,880	11.76	0	-120
59 PI	140	1,646	11.757	0			140	-1,646
3 AltaCorp	1,000	11,795	11.795	500	5,960	11.92	500	-5,835
132 Acker Finley	500	5,875	11.75	0			500	-5,875
99 Jitney	42,100	498,866	11.85	41,400	490,444	11.846	700	-8,422
70 Manulife	2,345	27,714	11.818	0			2,345	-27,714
57 Interactive	3,537	41,826	11.825	65	767	11.80	3,472	-41,059
88 Credential	4,418	52,448	11.871	597	7,087	11.871	3,821	-45,361
74 GMP	4,454	52,313	11.745	0			4,454	-52,313
19 Desjardins	37,395	441,436	11.805	32,596	385,319	11.821	4,799	-56,117
62 Haywood	5,600	66,256	11.831	0			5,600	-66,256
90 Barclays	7,600	89,562	11.784	0			7,600	-89,562
14 ITG	11,388	134,899	11.846	2,800	33,002	11.786	8,588	-101,897
72 Credit Suisse	14,360	169,638	11.813	2,832	33,219	11.73	11,528	-136,419
58 Qtrade	25,862	305,724	11.821	8,550	100,871	11.798	17,312	-204,853
2 RBC	323,586	3,833,674	11.847	299,675	3,534,818	11.796	23,911	-298,856
124 Questrade	102,290	1,206,706	11.797	74,106	873,082	11.782	28,184	-333,624
80 National Bank	49,148	579,957	11.80	14,825	175,322	11.826	34,323	-404,635
22 Fidelity	43,640	516,000	11.824	8,873	104,737	11.804	34,767	-411,263
85 Scotia	275,590	3,255,354	11.812	202,975	2,394,454	11.797	72,615	-860,900
53 Morgan Stanley	111,126	1,308,736	11.777	3,250	38,217	11.759	107,876	-1,270,519
7 TD Sec	715,779	8,459,019	11.818	585,168	6,928,275	11.84	130,611	-1,530,744
TOTAL	4,299,528	50,805,736	11.817	4,299,528	50,805,736	11.817	0	0

Trump signals support for legislation easing U.S. pot ban

LOS ANGELES -- President Donald Trump said Friday that he's inclined to support a bipartisan effort in Congress to ease the U.S. ban on marijuana, a proposal that would dramatically reshape the nation's legal landscape for pot users and businesses.

The federal ban that puts marijuana on the same level as LSD and heroin has created a conflict with more than two dozen states that have legalized pot in some form.

The legislation would ensure states have the right to determine the best approach to marijuana within their borders, but some U.S. restrictions would remain, including recreational sales to people under 21.

The proposal introduced Thursday has support from members of Congress from both parties, including Republican U.S. Sen. Cory Gardner of Colorado.

"I support Senator Gardner. I know exactly what he's doing," Trump told reporters in Washington, when asked about the legislation. "We're looking at it. But I probably will end up supporting that, yes."

In a statement released Thursday, Gardner said the proposal would ensure Washington respects the will of voters in each state, whether laws provide for legalization or prohibition.

He said the federal government "is closing its eyes and plugging its ears" to spreading legalization, but Washington should not interfere with any state's legal marijuana market.

Another co-sponsor, Democratic U.S. Sen. Elizabeth Warren of Massachusetts, said in a statement that Washington "needs to get out of the business of outlawing marijuana."

California, home to one in eight Americans, launched the nation's largest legal marijuana marketplace on Jan. 1. Still, businesses that have been licensed across the state are facing the threat of federal prosecution.

https://www.bnnbloomberg.ca/trump-signals-support-for-legislation-easing-u-s-pot-ban-1.1090240

Aphria News: "we are ready to serve the recreational adult use market and meet the needs of Canadians"

We are ready to serve the recreational adult use market and meet the needs of Canadians. 

Aphria Welcomes Passage of Bill C-45 in Senate, Ready to Meet Demand for Adult-Use Cannabis in Canada

Canada NewsWire

LEAMINGTON, ON, June 8, 2018

LEAMINGTON, ON, June 8, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today provided the following statement in reaction to the passage of Bill C-45, the Cannabis Act, in the Senate of Canada:  

Vic Neufeld, CEO of Aphria, said, "Today's passage of Bill C-45 through the Senate is a historic milestone towards safe and legal recreational cannabis in Canada. We applaud the government's drive to establish a rational regulatory framework for adult-use cannabis that is designed to protect public health and safety, restrict access to youth, and eliminate the black market. It is a significant day that further cements Canada as the preeminent leader in the global cannabis sector."

"While we share the government's goal to create a highly regulated market, we want to ensure that the cannabis industry is well positioned to responsibly meet the needs of Canadians and effectively compete with the black market, which is operating and marketing unbound by ethical or regulatory considerations. To do this, we believe that is critical that licensed producers be allowed to use limited forms of adult focused branding to properly educate Canadians about the differences between illegal and legal products. We also continue to advocate to exempt medicinal cannabis from excise taxes to ensure that it is subject to the same considerations as other medications. We encourage government to consider these changes as Bill C-45 passes through the final stages of legalization."

"As Canada moves one step closer to adult-use cannabis legalization, 

Aphria is well positioned as a global leader in the exciting cannabis market. With growing production capacity, innovative products, R&D expertise as well as talented and experienced people, we are ready to serve the recreational adult use market and meet the needs of Canadians. We look forward to working with government as a long-term partner to continue to position Canada as global success story," added Mr. Neufeld.

About Aphria

Aphria Inc., one of Canada's lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada, Aphria is truly powered by sunlight allowing for the most natural growing conditions available. Aphria is committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders.

For more information, visit: aphria.ca

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, estimated margins, expectations with respect to actual production volumes, expectations for future growing capacity and costs, the completion of any capital project or expansions, and expectations with respect to future production costs. 

Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

SOURCE Aphria Inc.

APH Anon Biggest Seller Again Hammering APH Net Gain $7,425,427

1 Anonymous

1,500,432

17,637,400

11.755

2,124,992

25,062,827

11.794

-624,560

$7,425,427

House Positions for C:APH from 20180608 to 20180608

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
1 Anonymous	1,500,432	17,637,400	11.755	2,124,992	25,062,827	11.794	-624,560	7,425,427
79 CIBC	1,220,118	14,360,835	11.77	1,486,417	17,520,646	11.787	-266,299	3,159,811
53 Morgan Stanley	39,255	465,801	11.866	95,380	1,112,424	11.663	-56,125	646,623
76 Industrial Alliance	0			47,500	551,032	11.601	-47,500	551,032
43 Caldwell	0			40,000	470,023	11.751	-40,000	470,023
15 UBS	3,716	43,705	11.761	33,910	396,063	11.68	-30,194	352,358
65 Goldman	400	4,789	11.973	13,300	154,497	11.616	-12,900	149,708
36 Latimer	6,529	76,761	11.757	8,400	98,755	11.757	-1,871	21,994
3 AltaCorp	1,500	17,770	11.847	1,500	17,885	11.923	0	115
68 Leede	1,000	11,920	11.92	1,000	11,980	11.98	0	60
62 Haywood	3,600	42,336	11.76	3,600	42,948	11.93	0	612
70 Manulife	580	6,773	11.678	500	5,780	11.56	80	-993
25 Odlum	200	2,362	11.81	0			200	-2,362
48 Laurentian	500	5,870	11.74	0			500	-5,870
99 Jitney	116,200	1,367,957	11.772	115,600	1,362,258	11.784	600	-5,699
22 Fidelity	38,224	451,723	11.818	37,514	442,141	11.786	710	-9,582
56 Edward Jones	1,200	14,192	11.827	0			1,200	-14,192
88 Credential	1,806	21,503	11.906	410	4,738	11.556	1,396	-16,765
90 Barclays	4,400	51,835	11.781	40	469	11.725	4,360	-51,366
28 BBS	8,485	99,130	11.683	3,730	43,351	11.622	4,755	-55,779
57 Interactive	6,799	79,982	11.764	1,851	21,798	11.776	4,948	-58,184
89 Raymond James	5,250	61,310	11.678	0			5,250	-61,310
14 ITG	16,719	197,243	11.798	10,350	122,486	11.834	6,369	-74,757
39 Merrill Lynch	234,236	2,778,907	11.864	227,492	2,668,072	11.728	6,744	-110,835
83 Mackie	10,000	115,998	11.60	0			10,000	-115,998
58 Qtrade	17,510	206,596	11.799	7,045	83,159	11.804	10,465	-123,437
72 Credit Suisse	12,294	145,387	11.826	200	2,352	11.76	12,094	-143,035
74 GMP	13,595	161,100	11.85	500	5,900	11.80	13,095	-155,200
19 Desjardins	63,261	746,339	11.798	45,036	530,784	11.786	18,225	-215,555
33 Canaccord	266,645	3,144,938	11.794	247,300	2,917,771	11.799	19,345	-227,167
143 Pershing	46,551	550,876	11.834	17,190	202,951	11.806	29,361	-347,925
59 PI	36,350	422,842	11.633	3,112	36,549	11.745	33,238	-386,293
124 Questrade	162,878	1,916,367	11.766	119,925	1,409,188	11.751	42,953	-507,179
80 National Bank	183,861	2,165,739	11.779	113,287	1,328,659	11.728	70,574	-837,080
13 Instinet	233,219	2,751,187	11.797	157,079	1,835,870	11.688	76,140	-915,317
85 Scotia	456,208	5,382,835	11.799	316,709	3,714,545	11.729	139,499	-1,668,290
7 TD Sec	855,352	10,061,659	11.763	712,966	8,391,831	11.77	142,386	-1,669,828
2 RBC	454,297	5,338,968	11.752	243,790	2,868,339	11.766	210,507	-2,470,629
9 BMO Nesbitt	310,042	3,650,534	11.774	95,587	1,123,398	11.753	214,455	-2,527,136
TOTAL	6,333,212	74,561,469	11.773	6,333,212	74,561,469	11.773	0	0